Evidence map›Paper›PMID 36298669›Full record

ArticleViruses2022

Model-Based Analysis of SARS-CoV-2 Infections, Hospitalization and Outcome in Germany, the Federal States and Districts.

Christiane Dings, Katharina Martha Götz, Katharina Och, Iryna Sihinevich, Quirin Werthner, Sigrun Smola, Marc Bliem, Felix Mahfoud, Thomas Volk, Sascha Kreuer and 3 more

Abstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Ventricular arrhythmia burden in ICD patients during the second wave of the COVID-19 pandemic.Clinical research in cardiology : official journal of the German Cardiac Society · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christiane DingsDepartment of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.ORCID 0000-0001-6550-2819
Katharina Martha GötzDepartment of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.
Katharina OchDepartment of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.
Iryna SihinevichDepartment of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.
Quirin WerthnerDepartment of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.
Sigrun SmolaInstitute of Virology, Saarland University Medical Center, 66421 Homburg, Germany.ORCID 0000-0003-3289-6545
Marc BliemCompuGroup Medical (CGM), 56070 Koblenz, Germany.
Felix MahfoudDepartment of Internal Medicine III (Cardiology, Angiology, Intensive Care Medicine), Saarland University Medical Center and Saarland University Faculty of Medicine, 66421 Homburg, Germany.ORCID 0000-0002-4425-549X
Thomas VolkDepartment of Anesthesiology, University Hospital of the Saarland, 66421 Homburg, Germany.ORCID 0000-0001-5175-7159
Sascha KreuerDepartment of Anesthesiology, University Hospital of the Saarland, 66421 Homburg, Germany.
Jürgen RisslandInstitute of Virology, Saarland University Medical Center, 66421 Homburg, Germany.
Dominik SelzerDepartment of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.
Thorsten LehrDepartment of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.ORCID 0000-0002-8372-1465

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic challenged many national health care systems, with hospitals reaching capacity limits of intensive care units (ICU). Thus, the estimation of acute local burden of ICUs is critical for appropriate management of health care resources. In this work, we applied non-linear mixed effects modeling to develop an epidemiological SARS-CoV-2 infection model for Germany, with its 16 federal states and 400 districts, that describes infections as well as COVID-19 inpatients, ICU patients with and without mechanical ventilation, recoveries, and fatalities during the first two waves of the pandemic until April 2021. Based on model analyses, covariates influencing the relation between infections and outcomes were explored. Non-pharmaceutical interventions imposed by governments were found to have a major impact on the spreading of SARS-CoV-2. Patient age and sex, the spread of variant B.1.1.7, and the testing strategy (number of tests performed weekly, rate of positive tests) affected the severity and outcome of recorded cases and could reduce the observed unexplained variability between the states. Modeling could reasonably link the discrepancies between fine-grained model simulations of the 400 German districts and the reported number of available ICU beds to coarse-grained COVID-19 patient distribution patterns within German regions.

Indexed as

COVID-19SARS-CoV-2FemaleGermanyHospitalizationHumansMalePandemicsagecoronavirus disease 2019 (COVID-19)intensive caremathematical modelnon-pharmaceutical interventionsSARS-CoV-2sextesting strategyvariant of concern (VOC)

Identifiers

PMID36298669
PMCPMC9607468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.